Aarsland, Dag
Creese, Byron
Politis, Marios
Chaudhuri, K. Ray
ffytche, Dominic H.
Weintraub, Daniel
Ballard, Clive
Article History
First Online: 3 March 2017
Competing interests
: D.A. has received research support and/or honoraria from Astra-Zeneca, H. Lundbeck, Novartis Pharmaceuticals and GE Health, and serves as a paid consultant for H. Lundbeck and Axovant. K.R.C. has consulted and served on advisory boards for Britannia, AbbVie, Neuronova, Mundipharma and UCB, and has also served on advisory boards for Synapsus and Medtronic. He has received honoraria from Boehringer Ingelheim, GlaxoSmithKline, AbbVie, Britannia, UCB, Mundipharma, Otsuka and Zambon, and grants from Boehringer Ingelheim, GlaxoSmithKline, Britannia, AbbVie, UCB and Neuronova. He holds intellectual property rights for the KPP scale and the PDSS, and receives royalties for the books <i>Non-Motor Symptoms of Parkinson's Disease</i> and <i>Fastfacts: Parkinson's Disease</i>. C.B. declares grants and personal fees from Lundbeck and Acadia, and personal fees from Roche, Orion, GlaxoSmithKline, Otusaka, Heptares and Lilly. The other authors declare no competing interests.